Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-24
Ultrasonographic monitoring and early diagnosis of stroke

Article Category

Article available in the following languages:

Novel ultrasound device for stroke evaluation

Early diagnosis combined with close monitoring of a stroke patient is essential for optimum recovery. UMEDS, an EU funded project, has developed a multi-channel, multi-gate ultrasound device to detect micro-embolic signals (MES) in affected individuals.

Cerebrovascular disease, or stroke can be unnecessarily devastating if not diagnosed as early as possible or monitored correctly during the recovery period. Inaccurate analysis of the patient's condition can drastically cut the chances of attaining a good prognosis and can increase the likelihood of brain damage. UMEDS has developed and designed a novel ultrasound (US) echographic system to monitor for the presence of micro-embolisms and therefore improve treatment for stroke victims. The system has proved to be highly sensitive and was also effective during tests on patients undergoing cardiovascular surgery. One of the primary innovations of the system is its mobility in that it is composed of a single small electronic board. It also possesses high integrative capacity through a 2.0 USB port in any host PC. Furthermore, the technology is highly flexible and is potentially applicable in fields where early diagnosis in cardiovascular disease is required simply through the development of specialised software. The board is also easily reproducible and the prototype has been tested in various international laboratories. UMEDS project has therefore produced a non-invasive, easily transportable and adaptable means of assessment of damage in stroke patients. In this way, the brain tissue at risk can be salvaged and recovery maximised. One impact of this could be the limitation of the burden imposed by cardiovascular disease on health support in Europe. Technologically, it can provide a base for development of further miniaturisations with even greater mobility and flexibility.

Znajdź inne artykuły w tej samej dziedzinie zastosowania

Moja broszura 0 0